Aditxt (NASDAQ:ADTX) Stock Attempts To Bounce Back After The Recent Fall
Biotech innovation company having mission to improve immune system, Aditxt (NASDAQ:ADTX), on October 5, 2021 announced entering into transaction agreement for reaching definitive agreement by November 2021 end in order to acquire subsidiary AiPharma Global Holdings LLC, a firm focusing on discovering, developing as well as commercializing antiviral therapies. AiPharma Global, biopharmaceutical companyholding directly, or through global affiliates worldwide (excluding Japan), rights to Avigan/Reeqonus/Qifendaas well as formulations of favipiravir, is…